Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Joseph Cerbone

Dermatology Avenel, NJ Medical Doctor

NPI 1235173709 CMS profile 147205

1030 St Georges Ave, Suite 306, Avenel, NJ 07001

Open in the dashboard

General payments

$1,186

92 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Joseph Cerbone of Avenel, NJ is reported in the CMS Open Payments database as having received $1,186 across 92 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 37th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $302 22
2022 General $231 16
2021 General $322 28
2020 General $216 17
2019 General $115 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joseph Cerbone
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Joseph Cerbone were reported at $0. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Joseph Cerbone Dermatology median Middle half National median
2019 $115 $454 $129–$1,240 $163
2020 $216 $235 $81–$756 $114
2021 $322 $377 $108–$1,108 $132
2022 $231 $514 $143–$1,391 $149
2023 $302 $607 $159–$1,674 $160
2024 $0 $751 $204–$1,903 $164
2025 $0 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Pfizer Inc. $214 19 payments
  2. Mayne Pharma Inc. $165 14 payments
  3. Sun Pharmaceutical Industries Inc. $122 10 payments
  4. Genzyme Corporation $107 8 payments
  5. AbbVie, Inc. $102 7 payments
  6. Ortho Dermatologics, a division of Bausch Health US, LLC $65 5 payments
  7. Novartis Pharmaceuticals Corporation $63 4 payments
  8. LEO Pharma Inc. $61 4 payments
  9. Janssen Biotech, Inc. $56 4 payments
  10. Dermavant Sciences, Inc. $49 3 payments
  11. Other $182 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $1,172 91 payments
  2. Education $14 1 payment
Products named General payments · program years 2019–2023
  1. EUCRISA $198 18 payments
  2. DUPIXENT Immunology $140 10 payments
  3. ADBRY $61 4 payments
  4. ILUMYA $60 5 payments
  5. CIBINQO $55 4 payments
  6. Absorica LD $49 4 payments
  7. VTAMA $49 3 payments
  8. RINVOQ $48 3 payments
  9. DUPIXENT Inflammation And Immunology $42 3 payments
  10. SKYRIZI $41 3 payments
  11. Other $713 55 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

159

Median for Dermatology: 534

Drug cost

$53,240

Median for Dermatology: $67,151

Branded share of claims

8.2%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Dupixent Syringe Dupilumab Brand 13 $48,453
Halobetasol Propionate Generic 69 $3,315
Fluticasone Propionate Generic 42 $734
Clobetasol Propionate Generic 12 $535
Triamcinolone Acetonide Generic 12 $189
Amlodipine Besylate Generic 11 $14

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Records

92 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record